Applied Therapeutics Inc (NASDAQ:APLT)
| 1.34 Delayed Data As of 3:59pm ET |  +0.04 / +3.08%Today’s Change | 0.73 Today|||52-Week Range 19.14 | -85.03% Year-to-Date |
Latest APLT News | Press Releases
No recent news for Applied Therapeutics Inc.
Today’s Trading
| Previous close | 1.30 |
| Today’s open | 1.31 |
| Day’s range | 1.31 - 1.38 |
| Volume | 2,548 |
| Average volume (3 months) | 361,340 |
| Market cap | $33.8M |
Data as of 3:59pm ET, 08/17/2022
Growth & Valuation
| Earnings growth (last year) | +3.57% |
| Earnings growth (this year) | +30.00% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Kuros Biosciences AG | 0.00 | 0.00% |
| SYRSSyros Pharmaceutical... | -0.05 | -5.26% |
| ICCCImmuCell Corp | +0.24 | +3.06% |
| PLXProtalix Biotherapeu... | +0.01 | +0.82% |
Data as of 3:59pm ET, 08/17/2022
Financials
| Next reporting date | November 17, 2022 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$105.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
